![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Zhejiang Lepu Pharmaceutical Co., Ltd Taizhou City Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Clopidogrel hydrogen sulfate, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2024-001 - Rev 00
This Chemical Type CEP, issued on May 02, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2531 associated with this CEP further emphasizes